128 related articles for article (PubMed ID: 221547)
1. Production of hybridomas secreting monoclonal antibodies against the lympholine osteoclast activating factor.
Luben RA; Mohler MA; Nedwin GE
J Clin Invest; 1979 Jul; 64(1):337-41. PubMed ID: 221547
[TBL] [Abstract][Full Text] [Related]
2. Production of human/mouse hybridomas secreting a human lymphokine, osteoclast activating factor.
Nedwin GE; Mohler MA; Luben RA
Cell Immunol; 1984 Apr; 84(2):324-32. PubMed ID: 6368007
[TBL] [Abstract][Full Text] [Related]
3. Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors.
Torcia M; Lucibello M; Vannier E; Fabiani S; Miliani A; Guidi G; Spada O; Dower SK; Sims JE; Shaw AR; Dinarello CA; Garaci E; Cozzolino F
Exp Hematol; 1996 Jul; 24(8):868-74. PubMed ID: 8690044
[TBL] [Abstract][Full Text] [Related]
4. In vitro immunization as an adjunct to the production of hybridomas producing antibodies against the lymphokine osteoclast activating factor.
Luben RA; Mohler MA
Mol Immunol; 1980 May; 17(5):635-9. PubMed ID: 7194419
[No Abstract] [Full Text] [Related]
5. Hybridomas secreting monoclonal antibody with specificity for Toxoplasma gondii.
Sethi KK; Endo T; Brandis H
J Parasitol; 1980 Apr; 66(2):192-6. PubMed ID: 7391860
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies against mouse nerve growth factor produced by somatic cell hybrids.
Businaro R; Butler RH; Rubenstein AE; Revoltella RP
J Neurosci Res; 1981; 6(1):89-98. PubMed ID: 7218374
[TBL] [Abstract][Full Text] [Related]
7. Partial purification of osteoclast-activating factor from phytohemagglutinin-stimulated human leukocytes.
Luben RA; Mundy GR; Trummel CL; Raisz LG
J Clin Invest; 1974 May; 53(5):1473-80. PubMed ID: 4825237
[TBL] [Abstract][Full Text] [Related]
8. Use of the hybridoma technique for antibody production to group-specific antigens of avian oncornaviruses.
Sovová V; Cerná H; Dostálová V; Hlozánek I
Folia Biol (Praha); 1980; 26(5):366-8. PubMed ID: 6160063
[TBL] [Abstract][Full Text] [Related]
9. The biochemical and biological characterization of lymphocyte regulatory molecules. VI. Generation of a B cell hybridoma whose antibody product inhibits interleukin 2 activity.
Gillis S; Henney CS
J Immunol; 1981 May; 126(5):1978-84. PubMed ID: 6971316
[TBL] [Abstract][Full Text] [Related]
10. Production of hybridomas secreting monoclonal antibodies against components of normal and malignant cells.
Eshhar Z; Hurwitz E; Hadas E
Prog Clin Biol Res; 1980; 47():357-65. PubMed ID: 7193867
[TBL] [Abstract][Full Text] [Related]
11. [Studies on the interaction between cells infected with measles virus and anti-measles antibody. II. Production and application of monoclonal antibodies against measles virus].
Kuwajima S
Hokkaido Igaku Zasshi; 1986 Jan; 61(1):15-23. PubMed ID: 3516820
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.
Ozato K; Sachs DH
J Immunol; 1981 Jan; 126(1):317-21. PubMed ID: 6935293
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody against human interleukin 2 (IL 2). I. Purification of IL 2 for the production of monoclonal antibodies.
Stadler BM; Berenstein EH; Siraganian RP; Oppenheim JJ
J Immunol; 1982 Apr; 128(4):1620-4. PubMed ID: 6977565
[TBL] [Abstract][Full Text] [Related]
14. Production of mouse monoclonal antibodies against human HLA-A3 for use in microlymphocytotoxicity technique.
Yari F; Sareh S; Sadri A; Sharifi Z; Najafi F
Hum Antibodies; 2009; 18(3):119-22. PubMed ID: 19729806
[TBL] [Abstract][Full Text] [Related]
15. Observations on the mechanism of bone resorption induced by multiple myeloma marrow culture fluids and partially purified osteoclast-activating factor.
Josse RG; Murray TM; Mundy GR; Jez D; Heersche JN
J Clin Invest; 1981 May; 67(5):1472-81. PubMed ID: 6262378
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
Brenner BG; Jothy S; Shuster J; Fuks A
Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to guinea pig Ia antigens. I. Production, serologic, and immunochemical characterization.
Burger R; Clement L; Schroer J; Chiba J; Shevach EM
J Immunol; 1981 Jan; 126(1):32-7. PubMed ID: 6935294
[TBL] [Abstract][Full Text] [Related]
18. [The value of good Biozzi antibody-producing strains of mice for the production of monoclonal antibodies].
Boumsell L; Bernard A
C R Seances Acad Sci D; 1979 Oct; 289(10):723-4. PubMed ID: 118822
[TBL] [Abstract][Full Text] [Related]
19. [Isolation of a cellular hybrid secreting an antibody specific for human leukocyte interferon].
Montagnier L; Laurent AG; Gruest J
C R Seances Acad Sci D; 1980 Nov; 291(11):893-6. PubMed ID: 6162583
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody specific for T cell-derived human IgE binding factors.
Kisaki T; Huff TF; Conrad DH; Yodoi J; Ishizaka K
J Immunol; 1987 May; 138(10):3345-51. PubMed ID: 2437189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
